Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.2977Source: DataRank Database

Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.53)OA: hybridTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Wei Liu ORCID,Luke E. Zabotka,Andreas Freitag ORCID,Ravinder Claire ORCID,Grace Wangge ORCID

Live enrichment

PubMed:37342987 PMC:PMC12024729 OpenAlex:https://openalex.org/W4381597452

NIA NIH HHS

Grant: R01 AG077620

NIA NIH HHS

Grant: K01 AG073651

NIA NIH HHS

Grant: R21 AG061632

NIA NIH HHS

Grant: R03 AG070661

NIA NIH HHS

Grant: R01 AG065722

FDA HHS

Grant: U01 FD007213

International Society for Pharmacoepidemiology

FWCI

1.53

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

hybridLicense: other-oa

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2977

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2977

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2977

journalhttps://doi.org/10.1002/cpt.2977

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37342987

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Sepsis Diagnosis and TreatmentAdultChildHumansMaleFemaleCOVID-19Post-Acute COVID-19 SyndromePharmacoepidemiologyPrognosisHospitalization

MeSH Terms

COVID-19Post-Acute COVID-19 SyndromeAdultChildFemaleHospitalizationHumansMalePrognosisPharmacoepidemiology

Keywords

Coronavirus disease 2019 (COVID-19)PharmacoepidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicinePharmacologyVirologyInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being